Apr 17, 2013 - Blog by Ingrid Evans | Share
– ATTORNEY NEWSLETTER – Amgen, Inc., a California-based biotechnology company, agrees to pay a $2.9 million settlement after allegations of marketing their products to patients who did not fit the approved labeling by the Food & Drug Administration. The product in subject, […]